Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CA 125 Antigen”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableUnknownNCT04867109
What this trial is testing

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

Who this might be right for
Endometrial NeoplasmsPostmenopauseUterine Hemorrhage+2 more
Nantes University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00004064
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AltaRex 102
Testing effectiveness (Phase 2)UnknownNCT04938583
What this trial is testing

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV
CanariaBio Inc. 54
Not applicableUnknownNCT02247323
What this trial is testing

Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125

Who this might be right for
Ovarian Cancer
Beni-Suef University 200
Testing effectiveness (Phase 2)Looking for participantsNCT07022535
What this trial is testing

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
The University of Hong Kong 18
Early research (Phase 1)Looking for participantsNCT04811703
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Who this might be right for
Metastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more
Hospices Civils de Lyon 15
Testing effectiveness (Phase 2)Ended earlyNCT01685255
What this trial is testing

The IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Who this might be right for
Ovarian CancerGenitourinary (GU) Tumors
Incyte Corporation 83
Not applicableStudy completedNCT02420769
What this trial is testing

Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion

Who this might be right for
Threatened Abortion
Nesreen Abdel Fattah Abdullah Shehata 100
Not applicableLooking for participantsNCT02296307
What this trial is testing

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Who this might be right for
Ovarian Neoplasms
McGill University 13,600
Not applicableStudy completedNCT01924117
What this trial is testing

Genotypification and Predisposing Factors in Human Papilloma Virus Infection

Who this might be right for
Intraepithelial Neoplasia
Materno-Perinatal Hospital of the State of Mexico 129
Not applicableStudy completedNCT02091557
What this trial is testing

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Who this might be right for
Pelvic PainEndometriosis
University Magna Graecia 118
Testing effectiveness (Phase 2)Study completedNCT01111903
What this trial is testing

A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse

Who this might be right for
Ovarian Cancer Recurrent
ARCAGY/ GINECO GROUP 67
Not applicableStudy completedNCT06977334
What this trial is testing

IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection

Who this might be right for
Ovarian NeoplasmsOvarian CancerOvarian Carcinoma
Maharajgunj Medical Campus 64
Testing effectiveness (Phase 2)UnknownNCT00305838
What this trial is testing

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 200
Not applicableLooking for participantsNCT00539162
What this trial is testing

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 8,000
Post-approval studies (Phase 4)Study completedNCT02008110
What this trial is testing

Carbohydrate Antigen 125-guided Therapy in Heart Failure

Who this might be right for
Heart Failure
Fundación para la Investigación del Hospital Clínico de Valencia 360
Post-approval studies (Phase 4)Study completedNCT01753154
What this trial is testing

The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis

Who this might be right for
Chronic Renal Failure
Fresenius Medical Care Deutschland GmbH 25
Not applicableStudy completedNCT02326064
What this trial is testing

Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4

Who this might be right for
Ovarian TumorOvarian Cancer
Centre Hospitalier Departemental Vendee 221
Large-scale testing (Phase 3)Study completedNCT00002895
What this trial is testing

Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical Research Council 1,400
Not applicableStudy completedNCT00587093
What this trial is testing

Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 669
Load More Results